Metabolism in Humans of Cis-12,trans-15-octadecadienoic Acid Relative to Palmitic, Stearic, Oleic and Linoleic Acids
Overview
Affiliations
Mixtures of triglycerides containing deuterium-labeled hexadecanoic acid (16:0), octadecanoic acid (18:0), cis-9-octadecenoic acid (9c-18:1), cis-9,cis-12-octadecadienoic acid (9c, 12c-18:2) and cis-12,trans-15-octadecadienoic acid (12c,15t-18:2) were fed to two young-adult males. Plasma lipid classes were isolated from samples collected periodically over 48 hr. Incorporation and turnover of the deuterium-labeled fats in plasma lipids were followed by gas chromatography-mass spectrometry (GC-MS) analysis of the methyl ester derivatives. Absorption of the deuterated fats was followed by GC-MS analysis of chylomicron triglycerides isolated by ultracentrifugation. Results were the following: (i) endogenous fat contributed about 40% of the total fat incorporated into chylomicron triglycerides; (ii) elongation, desaturation and chain-shortened products from the deuterated fats were not detected; (iii) the polyunsaturated isomer 12c,15t-18:2 was metabolically more similar to saturated and 9c-18:1 fatty acids than to 9c,12c-18:2; (iv) relative incorporation of 9c,12c-18:2 into phospholipids did not increase proportionally with an increase of 9c,12c-18:2 in the mixture of deuterated fats fed; (v) absorption of 16:0, 18:0, 9c-18:1, 9c,12c-18:2 and 12c,15t-18:2 were similar; and (vi) data for the 1- and 2-acyl positions of phosphatidylcholine and for cholesteryl ester fractions reflected the known high specificity of phosphatidylcholine acyltransferase and lecithin:cholesteryl acyltransferase for 9c,12c-18:2. These results illustrate that incorporation of dietary fatty acids into human plasma lipid classes is selectively controlled and that incorporation of dietary 9c,12c-18:2 is limited. These results suggest that nutritional benefits of diets high in 9c,12c-18:2 may be of little value to normal subjects and that the 12c,15t-18:2 isomer in hydrogenated fat is not a nutritional liability at the present dietary level.
Butcko A, Putman A, Mottillo E Antioxidants (Basel). 2024; 13(1).
PMID: 38247511 PMC: 10812494. DOI: 10.3390/antiox13010087.
Preparation of methyl 5,11,14,17-eicosatetraenoate-8,8,9,9-d 4.
Rakoff H Lipids. 2016; 28(1):47-50.
PMID: 27519766 DOI: 10.1007/BF02536359.
The Essentiality of Arachidonic Acid in Infant Development.
Hadley K, Ryan A, Forsyth S, Gautier S, Salem Jr N Nutrients. 2016; 8(4):216.
PMID: 27077882 PMC: 4848685. DOI: 10.3390/nu8040216.
van Hees N, Giltay E, Geleijnse J, Janssen N, van der Does W PLoS One. 2014; 9(5):e97778.
PMID: 24841484 PMC: 4026409. DOI: 10.1371/journal.pone.0097778.
Hodson L, McQuaid S, Karpe F, Frayn K, Fielding B Am J Physiol Endocrinol Metab. 2008; 296(1):E64-71.
PMID: 18940935 PMC: 2636984. DOI: 10.1152/ajpendo.90730.2008.